There is an unmistakable pattern.
Slowing the disease's progression isn't enough.
The FDA and CDC are already halting the use of the COVID-19 vaccine on federal sites.
The real-world data study in Israel had a small sample size but provided interesting results that are worth looking into.
The researchers worked hard to identify blood biomarkers for neuropsychiatric disorders — and they were successful.
This pandemic might be far from being over, but it is crucial for us to keep an eye on the next pandemic.
A viable HIV vaccine could use Moderna's mRNA technology.
Turns out, our rodent friends engage in social distancing, too.
Moreover, it offers a high level of protection against COVID-19 six months after the second dose.